DNAJB4 and neoplasm: In addition to our finding that DNAJB4 has an independent impact on advanced-stage cancers, research on molecular biomarkers, such as DNAJB4, has revealed critical mechanisms in tumor progression, supporting their potential to supplement the TNM system towards a more individualized and accurate patient management.